Release Date: 23/10/18 08:27 Summary: Strong drill results flag further growth at Bombora Price Sensitive: Yes Download Document 5MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%